A 72-week trial in adults with obesity found an average of 20.2% change in body weight with tirzepatide versus 13.7% with semaglutide
Ingredients Each vegetable capsule Non-Medicinal Ingredients Dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide
Unfortunately, a phase II clinical trial of UBX0101 (NCT03513016) was completed in patients with osteoarthritis and the promising results observed (Table 1), in vitro and in vivo, have not been up to the expectations in treated patients, leading only to a decrease of pain, without a significant improvement of the disease 30
She discusses the critical need for nutritional education, muscle preservation, and holistic support for patients using these medications long-term